APELLIS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.05 USD | -1.08% |
|
-0.15% | -31.42% |
| May. 31 | Piper Sandler Starts Apellis Pharmaceuticals With Neutral Rating, $46 Price Target | MT |
| May. 24 | Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-03 | 2024-06-04 | 2024-06-05 | 2024-06-06 | |
|---|---|---|---|---|
| Last | 40.11 $ | 39.83 $ | 41.5 $ | 41.05 $ |
| Volume | 1 023 268 | 924 350 | 1 326 383 | 723 083 |
| Change | +2.19% | -0.70% | +4.19% | -1.08% |
| Opening | 39.57 | 39.72 | 40.06 | 41.65 |
| High | 41.71 | 40.19 | 41.69 | 41.66 |
| Low | 39.00 | 38.67 | 39.51 | 40.51 |
Performance
| 1 day | -1.08% | ||
| 1 week | -0.15% | ||
| Current month | +4.59% | ||
| 1 month | -13.51% | ||
| 3 months | -34.29% | ||
| 6 months | -36.67% | ||
| Current year | -31.42% | ||
| 1 year | -54.28% | ||
| 3 years | -28.15% | ||
| 5 years | +91.64% |
Volumes
marketsDaily volume
1 061 810
Estimated daily volume
1 061 810
Avg. Volume 20 sessions
1 272 029
Daily volume ratio
0.83
Avg. Volume 20 sessions USD
52 216 790.45
Record volume 1
30 877 960
Record volume 2
24 724 674
Record volume 3
21 426 108
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
5 036 670 532
Net sales (USD)
396 591 000
Number of employees
704
Sales / Employee (USD)
563 339
Free-Float
85.68 %
Free-Float capitalization (USD)
4 315 228 224
Average Daily Capital Traded
1.04%
Highs and lows
1 week
38.35
41.71
1 month
38.3547.60
Current year
38.2273.80
1 year
19.8394.75
3 years
19.8394.75
5 years
16.8594.75
10 years
11.4594.75
Indicators
Moving average 5 days
40.28
Moving average 20 days
41.57
Moving average 50 days
47.86
Moving average 100 days
55.74
Price spread / (MMA5)
-1.88%
Price spread / (MMA20)
+1.27%
Price spread / (MMA50)
+16.60%
Price spread / (MMA100)
+35.77%
STIM
RSI 9 days
38.45
RSI 14 days
37.99
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.08% | -0.15% | -31.42% | -54.28% | 5.04B | ||
| +1.27% | +4.06% | +0.99% | -6.83% | 91.72B | ||
| +0.93% | +4.54% | 0.00% | -3.18% | 39.44B | ||
| -2.00% | +8.20% | -10.35% | -23.22% | 34.47B | ||
| +0.31% | +2.12% | +64.64% | +56.81% | 26.7B | ||
| +1.48% | +7.71% | -16.15% | -11.86% | 15.13B | ||
| -1.05% | +2.62% | -6.98% | -6.35% | 13.27B | ||
| -1.21% | -0.42% | -11.77% | +2.41% | 11.74B | ||
| -2.70% | -5.79% | -49.19% | -34.06% | 10.54B | ||
| +1.48% | +5.79% | +8.09% | +34.23% | 9.41B | ||
| +1.93% | +30.70% | +141.62% | +395.32% | 9.22B | ||
| -3.64% | -0.14% | -16.37% | -3.25% | 7.73B | ||
| +1.09% | +3.02% | -4.29% | +8.45% | 7.16B | ||
| +1.82% | +10.99% | +1.20% | +15.79% | 6.99B | ||
| +2.09% | +2.23% | -8.50% | +3.24% | 6.53B | ||
| -1.70% | +3.89% | -39.46% | -19.59% | 6.26B | ||
| Average | -0.06% | +5.27% | +1.38% | +22.10% | ||
| Weighted average by Cap. | +0.27% | +4.61% | +4.11% | +10.31% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
35e60b6a4b43d9043f1fe58be789818.vkukHcNbZKpTK5BgHD5M3SuLkyFbjNuHcymZqoCAILA.1j7eS4UhDcMZbtg1X3l5jnrxy1kT9bWyHF3p5rOtV8n5JM8tshYp-2VOxQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 41.05 | 98,475 | 407,868 |
| 03:59:59 pm | 41.05 | 100 | 309,393 |
| 03:59:59 pm | 41.05 | 849 | 309,293 |
| 03:59:59 pm | 41.05 | 129 | 308,444 |
| 03:59:58 pm | 41.07 | 100 | 308,315 |
| 03:59:54 pm | 41.08 | 100 | 308,215 |
| 03:59:54 pm | 41.08 | 100 | 308,115 |
| 03:59:54 pm | 41.1 | 100 | 308,015 |
| 03:59:54 pm | 41.1 | 100 | 307,915 |
| 03:59:53 pm | 41.1 | 100 | 307,815 |
Monthly variations
Annual change
| 2024 | -31.42% | ||
| 2023 | +15.76% | ||
| 2022 | +9.37% | ||
| 2021 | -17.34% | ||
| 2020 | +86.81% | ||
| 2019 | +132.15% | ||
| 2018 | -39.22% | ||
| 2017 | +54.67% |
- Stock Market
- Equities
- APLS Stock
- Quotes Apellis Pharmaceuticals, Inc.
